BCYC Stock Analysis: Buy, Sell, or Hold?
BCYC - Bicycle Therapeutics plc American Depositary Shares
$3.87
0.01 (0.26%)
▲
5d:
-2.03%
30d:
-11.03%
90d:
-19.37%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 14, 2026
10d
Get Alerted When BCYC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BCYC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BCYC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BCYC is currently trading at $3.87, which is considered oversold relative to its 30-day fair value range of $3.98 to $4.31.
Technical Outlook: Technically, BCYC is in a strong downtrend. Immediate support is located at $3.75, while resistance sits at $4.33.
Market Sentiment: BCYC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.86 (+154.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BCYC is in a strong downtrend. Immediate support is located at $3.75, while resistance sits at $4.33.
Market Sentiment: BCYC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.86 (+154.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.98 -
$4.31
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 154.7% below Wall St target ($9.86)
Trading Range Analysis
30-Day Trading Range
$3.98 -
$4.31
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.75
Resistance Level
$4.34
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.75
Wall Street Target
$9.86
(+154.7%)
Revenue Growth (YoY)
-78.5%
Share & Embed Analysis
Last updated: August 03, 2026 5:50 PM ET
Data refreshes hourly during market hours. Next update: 6:50 PM
Data refreshes hourly during market hours. Next update: 6:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCYC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Lee
SELL
1716 shares
2026-04-06
Travis Alvin Thompson
SELL
102 shares
2026-04-06
Jennifer Scott Perry
SELL
370 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
